Literature DB >> 35121872

The immuno-oncological challenge of COVID-19.

Lisa Derosa1,2,3, Cléa Melenotte1,2,4,5, Franck Griscelli1,6, Bertrand Gachot1,7, Aurélien Marabelle1,2,3, Guido Kroemer8,9,10,11,12, Laurence Zitvogel13,14,15,16,17.   

Abstract

Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose considerable challenges for the management of oncology patients. COVID-19 presents as a particularly severe respiratory and systemic infection in aging and immunosuppressed individuals, including patients with cancer. Moreover, severe COVID-19 is linked to an inflammatory burst and lymphopenia, which may aggravate cancer prognosis. Here we discuss why those with cancer are at higher risk of severe COVID-19, describe immune responses that confer protective or adverse reactions to this disease and indicate which antineoplastic therapies may either increase COVID-19 vulnerability or have a dual therapeutic effect on cancer and COVID-19.
© 2020. Springer Nature America, Inc.

Entities:  

Mesh：

Year:  2020        PMID： 35121872     DOI： 10.1038/s43018-020-00122-3

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


  147 in total

1.  [Cerebral blood flow dynamics in monkeys breathing a helium-oxygen mixture under high pressure].

Authors:  I T Demchenko; S Iu Zhiliaev; D N Atochin; O I Sharapov
Journal:  Fiziol Zh Im I M Sechenova       Date:  1994-02

Review 2.  Cardiac Transplantation: a review.

Authors:  H S Sadowsky
Journal:  Phys Ther       Date:  1996-05

3.  [Immunological studies in surgery of chronic suppurations of the lungs].

Authors:  V I Struchkov; L M Nedvetskaia; K N Prozorovskaia; Z V Smolina
Journal:  Grudn Khir       Date:  1974 Sep-Oct

4.  [Multivariate discrimination analysis of enzyme patterns in tumor patients].

Authors:  R Klöppel; H Zöllner; P Wieniecki; F Kamprad; W Oelssner
Journal:  Radiobiol Radiother (Berl)       Date:  1982-03

5.  Radiological case of the month: ileal atresia with meconium peritonitis: meconium pseudocyst.

Authors:  R A Boedecker; D P Babbitt; J R Sty; L W Young
Journal:  Am J Dis Child       Date:  1982-08

6.  [A case of hypopotassemic myopathy].

Authors:  O Sepe; R Valiani; A M Fasanaro; A Mandarini; A Verdoliva
Journal:  Acta Neurol Quad (Napoli)       Date:  1981

7.  Glycerol permeation of the human granulocyte.

Authors:  D C Dooley
Journal:  Exp Hematol       Date:  1982-05       Impact factor: 3.084

8.  Cost analysis and a forecast of fractures of the proximal femur in the Province of Middle Finland.

Authors:  P Lüthje
Journal:  Ann Chir Gynaecol       Date:  1982

9.  A case report of central nervous system lymphoma following immunosuppression.

Authors:  J Ingram; C S Benjamin
Journal:  Australas Radiol       Date:  1989-05

10.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996
View more
  17 in total

1.  Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol.

Authors:  Nicola Silvestris; Valeria Belleudi; Antonio Addis; Fulvia Pimpinelli; Aldo Morrone; Salvatore Sciacchitano; Rita Mancini; Vito Michele Garrisi; Massimo Costantini; Gennaro Ciliberto; Vincenza Frisardi; Giulia Piaggio
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

2.  [Covid-19 and breast cancer: First lessons of a pandemic].

Authors:  C Mathelin; M Lodi
Journal:  Gynecol Obstet Fertil Senol       Date:  2021-02-22

Review 3.  COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

Authors:  Larissa E van Eijk; Mathijs Binkhorst; Arno R Bourgonje; Annette K Offringa; Douwe J Mulder; Eelke M Bos; Nikola Kolundzic; Amaal E Abdulle; Peter Hj van der Voort; Marcel Gm Olde Rikkert; Johannes G van der Hoeven; Wilfred Fa den Dunnen; Jan-Luuk Hillebrands; Harry van Goor
Journal:  J Pathol       Date:  2021-03-25       Impact factor: 9.883

4.  Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.

Authors:  Stephen J Thomas; John L Perez; Stephen P Lockhart; Subramanian Hariharan; Nicholas Kitchin; Ruth Bailey; Katherine Liau; Eleni Lagkadinou; Özlem Türeci; Ugur Şahin; Xia Xu; Kenneth Koury; Samuel S Dychter; Claire Lu; Teresa C Gentile; William C Gruber
Journal:  Vaccine       Date:  2021-12-24       Impact factor: 3.641

5.  Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis.

Authors:  Md Mohiuddin; Kazuo Kasahara
Journal:  J Infect Public Health       Date:  2021-12-10       Impact factor: 3.718

6.  Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.

Authors:  Marc A Schneider; Sarah Richtmann; Anna R Gründing; Sabine Wrenger; Tobias Welte; Michael Meister; Mark Kriegsmann; Hauke Winter; Thomas Muley; Sabina Janciauskiene
Journal:  Int J Oncol       Date:  2022-02-25       Impact factor: 5.650

7.  COVID-19 vaccination and breakthrough infections in patients with cancer.

Authors:  A L Schmidt; C Labaki; C-Y Hsu; Z Bakouny; N Balanchivadze; S A Berg; S Blau; A Daher; T El Zarif; C R Friese; E A Griffiths; J E Hawley; B Hayes-Lattin; V Karivedu; T Latif; B H Mavromatis; R R McKay; G Nagaraj; R H Nguyen; O A Panagiotou; A J Portuguese; M Puc; M Santos Dutra; B A Schroeder; A Thakkar; E M Wulff-Burchfield; S Mishra; D Farmakiotis; Yu Shyr; J L Warner; T K Choueiri
Journal:  Ann Oncol       Date:  2021-12-24       Impact factor: 32.976

8.  Global analysis of within-host SARS-CoV-2/HIV coinfection model with latency.

Authors:  A M Elaiw; A D Al Agha; S A Azoz; E Ramadan
Journal:  Eur Phys J Plus       Date:  2022-01-27       Impact factor: 3.758

Review 9.  Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.

Authors:  Muhammad Bilal Latif; Sudhanshu Shukla; Perla Mariana Del Rio Estrada; Susan Pereira Ribeiro; Rafick Pierre Sekaly; Ashish Arunkumar Sharma
Journal:  Transl Res       Date:  2021-12-03       Impact factor: 7.012

Review 10.  Challenges posed by COVID-19 in cancer patients: A narrative review.

Authors:  Zeinab Mohseni Afshar; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour; Amirmasoud Alijanpour; Babak Sayad; Dariush Hosseinzadeh; Seyed Rouhollah Miri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Arefeh Babazadeh
Journal:  Cancer Med       Date:  2021-12-23       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.